Pfizer works to discover and develop innovative, safe, and effective ways to prevent or treat some of the world’s most challenging diseases. In New Zealand, Pfizer typically undertakes several clinical trials in a variety of disease areas - locally investing over $2million per year in the process.
Clinical trials are human tests that help doctors understand if a new medicine is more effective or safer than existing medicines or treatments, and to determine the appropriate dosage of the new medicine. We are committed to the safety of patients who take part in our trials, and uphold the highest ethical standards in all of our research initiatives.
Results from clinical trials can lead to the development of medicines that can prevent death and also improve the lives of people suffering from a diverse range of challenging medical conditions.